首页> 外文期刊>The American heart journal >Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading
【24h】

Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading

机译:大剂量氯吡格雷负荷后东亚患者血管扩张剂刺激的磷蛋白磷酸化测定与透光度聚集度的关系

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives We analyzed the relation between platelet aggregation measured by light transmittance aggregometry (LTA) and platelet reactivity index (PRI) measured by vasodilator-stimulated phosphoprotein phosphorylation (VASP-P) assay. Background It has been suggested that LTA and VASP-P assay correlate differently according to the level of P2Y12 receptor blockade by thienopyridines. Methods We simultaneously measured platelet function by LTA and VASP-P assay in 466 East Asians undergoing elective percutaneous coronary intervention after a 600-mg clopidogrel loading. High on-clopidogrel platelet reactivity (HPR) was defined by published consensus criteria. Results The degree of correlation between LTA and the VASP-P assay was different according to PRI levels. The correlation was lower in patients with poor responsiveness (PRI 60%) (n = 216) (0.035 ≤ r2 ≤ 0.047), which was greater in responsive patients (PRI ≤60%) (n = 250) (0.315 ≤ r2 ≤ 0.526). Despite a 600-mg loading, East Asians had a high prevalence of HPR (40.1%-63.5%), and the prevalence of HPR also differed between LTA and VASP-P assay. A PRI cutoff of 58% (area under curve, 0.829; 95% confidence intervals, 0.792-0.862; P .001) corresponded to the published HPR cutoff by 5-μM adenosine diphosphate-induced maximal platelet aggregation 46%. Conclusions This is the largest study correlating platelet reactivity measured by LTA and VASP-P assay in a percutaneous coronary intervention-treated cohort. The correlation is dependent on the level of responsiveness. Future investigations are needed to better define the optimal cutoffs of HPR measured by LTA and VASP-P assay for personalized antiplatelet therapy.
机译:目的我们分析了通过光透射聚集法(LTA)测量的血小板聚集与通过血管扩张剂刺激的磷蛋白磷酸化(VASP-P)分析测量的血小板反应性指数(PRI)之间的关系。背景技术已经提出,根据噻吩并吡啶类对P2Y12受体的阻断水平,LTA和VASP-P分析的相关性不同。方法我们采用LTA和VASP-P分析法同时测定了466例接受氯吡格雷剂量600 mg接受选择性经皮冠状动脉介入治疗的东亚人的血小板功能。氯吡格雷对血小板的高反应性(HPR)由已发表的共识标准定义。结果根据PRI水平,LTA和VASP-P分析之间的相关程度有所不同。反应性差的患者(PRI> 60%)(n = 216)(0.035≤r2≤0.047)的相关性较低,而反应性差的患者(PRI≤60%)(n = 250)(0.315≤r2≤ 0.526)。尽管有600毫克的负载量,东亚人的HPR患病率很高(40.1%-63.5%),LTA和VASP-P分析之间的HPR患病率也有所不同。 PRI临界值> 58%(曲线下面积0.829; 95%置信区间0.792-0.862; P <.001)对应于5-μM腺苷二磷酸诱导的最大血小板聚集> 46%的HPR临界值。结论这是在经皮冠状动脉介入治疗的队列研究中,通过LTA和VASP-P分析测定的与血小板反应性相关的最大研究。相关性取决于响应度。需要进行进一步的研究,以更好地定义通过LTA和VASP-P测定法测量的HPR最佳临界值,以用于个性化抗血小板治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号